| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/2008 | WO2008009866A2 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor |
| 01/24/2008 | WO2008009802A2 Drugs comprising an inhibitor of class 1 alpha mannosidase for the treatment of sarcoglycanopathies |
| 01/24/2008 | WO2008009798A1 Composition based on d-glucosamine, on lactoferrin and on chondroitin sulphate for preventing and/or treating degenerative joint diseases |
| 01/24/2008 | WO2008009758A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | WO2008009756A1 Injectable liquid paracetamol formulation |
| 01/24/2008 | WO2008009750A2 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | WO2008009741A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 01/24/2008 | WO2008009735A1 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
| 01/24/2008 | WO2008009734A1 Macrocyclic lactams |
| 01/24/2008 | WO2008009689A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/24/2008 | WO2008009665A1 Treatment of pain |
| 01/24/2008 | WO2008009664A2 Treatment of pain |
| 01/24/2008 | WO2008009663A1 Treatment of pain |
| 01/24/2008 | WO2008009639A2 New indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009638A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/24/2008 | WO2008009615A1 Dietary supplement for supporting mental and physical performance |
| 01/24/2008 | WO2008009613A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | WO2008009600A1 Process for producing arachidonic acid and/or eicosapentaenoic acid in plants |
| 01/24/2008 | WO2008009589A2 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 01/24/2008 | WO2008009487A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/24/2008 | WO2008009476A2 Concentrated methotrexate solutions |
| 01/24/2008 | WO2008009458A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | WO2008009435A1 Amino-piperidine derivatives as cetp inhibitors |
| 01/24/2008 | WO2008009426A1 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases |
| 01/24/2008 | WO2008009416A1 Spirocyclic azaindole derivatives |
| 01/24/2008 | WO2008009335A2 Aminoindazole urea derivatives |
| 01/24/2008 | WO2008009264A1 Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009212A1 A standardised extract and its use in the manufacture of a medicament |
| 01/24/2008 | WO2008009210A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 01/24/2008 | WO2008009209A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 01/24/2008 | WO2008009141A1 Methods and therapies for potentiating a therapeutic action of an alpha- 2 adrenergic receptor agonist and inhibiting and/or reversing tolerance to alpha- 2 adrenergic receptor agonists |
| 01/24/2008 | WO2008009138A1 Chlorogenic acid derivatives and their use as anti-fungal agents |
| 01/24/2008 | WO2008009127A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 01/24/2008 | WO2008009125A1 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 01/24/2008 | WO2008009122A1 Acrylamide derivatives as fab i inhibitors |
| 01/24/2008 | WO2008009078A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 01/24/2008 | WO2008009077A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| 01/24/2008 | WO2007143705A3 Organic compounds |
| 01/24/2008 | WO2007143014A3 Methods for preparing glutamic acid derivatives and intermediates thereof |
| 01/24/2008 | WO2007142905A3 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 01/24/2008 | WO2007140439A3 Compounds as cannabinoid receptor ligands and uses thereof |
| 01/24/2008 | WO2007140254A3 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 01/24/2008 | WO2007139948A3 Imidazoazepinone compounds |
| 01/24/2008 | WO2007139775A3 N-methanocarba derivatives to treat cardiac diseases |
| 01/24/2008 | WO2007138606A3 Multiple unit pharmaceutical formulation |
| 01/24/2008 | WO2007138233A3 Use of zatosetron for the treatment of rosacea, and pharmaceutical compositions |
| 01/24/2008 | WO2007137417B1 Heterocyclic compounds as calcium channel blockers |
| 01/24/2008 | WO2007137301A3 Modulation of chrebp expression |
| 01/24/2008 | WO2007137224A3 Method of treatment |
| 01/24/2008 | WO2007137196A3 Tubulin binding anti cancer compounds and prodrugs thereof |
| 01/24/2008 | WO2007137103A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/24/2008 | WO2007137080A3 Compounds and compositions as channel activating protease inhibitors |
| 01/24/2008 | WO2007137040A3 7-(acryloyl) indole compositions and methods for making and using same |
| 01/24/2008 | WO2007136776A3 Pyrimidine low molecular weight ligands for modulating hormone receptors |
| 01/24/2008 | WO2007136741A3 N-desmethyl-doxepin and methods of using the same to treat sleep disorders |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007136650A3 Method and compositions for treating hematological malignancies |
| 01/24/2008 | WO2007136326A3 ) t e text as een esta s e y t s ut o ty to rea as o ows: 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 3 |
| 01/24/2008 | WO2007135172A3 Cladribine regimen for treating multiple sclerosis |
| 01/24/2008 | WO2007135131A8 Substituted pyrazinone derivatives for use as a medicine |
| 01/24/2008 | WO2007133802A3 Pharmaceutical formulations of pimavanserin |
| 01/24/2008 | WO2007133653A3 Methods for treating blood disorders |
| 01/24/2008 | WO2007133481A3 Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
| 01/24/2008 | WO2007132438A3 Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative |
| 01/24/2008 | WO2007131907A3 1h-indol-5-yl-piperazin-1-yl-methanone derivatives |
| 01/24/2008 | WO2007130823A3 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
| 01/24/2008 | WO2007130075A8 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 01/24/2008 | WO2007129161A3 Thieno [3, 2-d] pyrimidine derivative useful as pi3k inhibitor |
| 01/24/2008 | WO2007128086A3 Novel viral replication inhibitor |
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | WO2007124733A3 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 01/24/2008 | WO2007123953A3 Phosphodiesterase 4 inhibitors |
| 01/24/2008 | WO2007122156A9 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |
| 01/24/2008 | WO2007120606A3 Methods for modulating formation and progression of cellulite |
| 01/24/2008 | WO2007113885A3 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them |
| 01/24/2008 | WO2007113212A3 Use of a kinase inhibitor for the treatment of particular resistant tumors |
| 01/24/2008 | WO2007112367A3 Potassium channel modulators and platelet procoagulant activity |
| 01/24/2008 | WO2007109093A3 Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | WO2007100894A3 Fluvastatin sodium novel forms and preparation therof |
| 01/24/2008 | WO2007096261A3 Process for the preparation of dioxane derivatives |
| 01/24/2008 | WO2007095147A3 Adhesive preparation comprising sufentanil and methods of using the same |
| 01/24/2008 | WO2007094819A3 Triazole compounds that modulate hsp90 activity |
| 01/24/2008 | WO2007089571A3 Method of treating chronic kidney disease |
| 01/24/2008 | WO2007084464A3 Water channel blockers and methods of use thereof |
| 01/24/2008 | WO2007084394A3 2,5 diaza-bicyclo[2.2.1]heptane derivatives as calcium channel blockers |
| 01/24/2008 | WO2007078618A3 Treatment of pain with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1h)-quinolone or salt thereof |
| 01/24/2008 | WO2007076245A3 Novel hydrogen sulfate salt |
| 01/24/2008 | WO2007070423A3 Topical glucocorticosteroid formulations |
| 01/24/2008 | WO2007066185A3 Polymorphs of a c-met/hgfr inhibitor |
| 01/24/2008 | WO2007062030A3 Quinuclidinone derivatives as anticancer agents |
| 01/24/2008 | WO2007061874A3 Methods and compositions for use in treating cancer |
| 01/24/2008 | WO2007056078A3 Certain chemical entities, compositions, and methods |
| 01/24/2008 | WO2007051811A3 Pharmaceutical use of substituted amides |
| 01/24/2008 | WO2007051810A3 Pharmaceutical use of substituted amides |
| 01/24/2008 | WO2007049265A3 Anti mineralocorticoid therapy of infection |
| 01/24/2008 | WO2007007042A8 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/24/2008 | WO2007006732A8 Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) |
| 01/24/2008 | WO2007005988A3 Process for preparing malathion for pharmaceutical use |